gvtcx

HPV Self-sampling cost effectiveness model

Department of Health and Social Care (London) Published 14 Oct 2024 Contracts Finder

key details

Value£299,852
Statuscomplete
Category (CPV) 73200000 +1 more
Deadline19 Aug 2024
Contract start14 Oct 2024
Contract end13 Apr 2026
Procedureopen
SME suitableYes
OCIDocds-b5fd17-573cf6bd-1284-4783-b3d3-dcb9946cea62

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £299,852.

SupplierValueDateStatus
The University of Sydney £299,852 13 Oct 2024 active
The University of Sydney £299,852 13 Oct 2024 active

description

The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV.

The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample. Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion.

Contract term: 18 months with the option to extend for a period of up to 6 months.

Contract value (including extensions): £249,876 excluding VAT (£299,852 including VAT).

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
14 Oct 2024 Award (award) · 267268b7-446f-4364-b380-c2fc69b6bea3-793627

more from Department of Health and Social Care (London)

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.